Citation Impact
Citing Papers
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
2008 StandoutNobel
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
2008
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Similar Nucleotide Excision Repair Capacity in Melanocytes and Melanoma Cells
2010 StandoutNobel
A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells
2005
Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
2009
Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens
2008
Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis
2013
Hallmarks of Cancer: The Next Generation
2011 Standout
Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system
2009
Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis
2006
Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma
2012
Viral RNA Induces Type I Interferon-Dependent Cytokine Release and Cell Death in Mesangial Cells via Melanoma-Differentiation-Associated Gene-5
2009 StandoutNobel
Increased PDGFRα Activation Disrupts Connective Tissue Development and Drives Systemic Fibrosis
2009
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Dasatinib
2009
Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors
2006
Analysis of the genome to personalize therapy for melanoma
2010
Gastrointestinal Stromal Tumors II: Medical Oncology and Tumor Response Assessment
2009
The FGF family: biology, pathophysiology and therapy
2009 Standout
Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor Prognosis
2006
Radiation Therapy: Uveal Tumors
2013
A quality control program for mutation detection in KIT and PDGFRA in gastrointestinal stromal tumours
2011
Targeting mast cells in inflammatory diseases
2014
Gastrointestinal stromal tumour
2007
The role of KIT in the management of patients with gastrointestinal stromal tumors
2007
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
2017 StandoutNobel
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
2005
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
A Molecular Brake in the Kinase Hinge Region Regulates the Activity of Receptor Tyrosine Kinases
2007
BRAF mutations are detectable in conjunctival but not uveal melanomas
2004
Beyond Imatinib: Second Generation c-KIT Inhibitors for the Management of Gastrointestinal Stromal Tumors
2006
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors
2008
Type I interferons in infectious disease
2015 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma
2008
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
MAP kinase signalling pathways in cancer
2007 Standout
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region
2010
GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology
2005
Monoclonal Antibody DOG1.1 Shows Higher Sensitivity Than KIT in the Diagnosis of Gastrointestinal Stromal Tumors, Including Unusual Subtypes
2009
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours
2008
The synthesis of Bcr-Abl inhibiting anticancer pharmaceutical agents imatinib, nilotinib and dasatinib
2012
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
2008 StandoutNature
Translation of new cancer treatments from pet dogs to humans
2008 Standout
KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)
2006
Malignant Gliomas in Adults
2008 Standout
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Molecular genetics in acute myeloid leukemia
2010
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
2019 Standout
DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors
2009
PDGFRA Immunostaining Can Help in the Diagnosis of Gastrointestinal Stromal Tumors
2008
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2020 Standout
Reactive oxygen species in cancer
2010 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Benefit-Risk Assessment of Sunitinib in Gastrointestinal Stromal Tumours and Renal Cancer
2009
Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST)
2009
Metabolism and Disposition of Dasatinib after Oral Administration to Humans
2008
Molecular Genetic Pathways as Therapeutic Targets in Acute Myeloid Leukemia
2008
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib
2008
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal Tumors
2008
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
Sarcoma molecular testing: Diagnosis and prognosis
2007
ROS signalling in the biology of cancer
2017 Standout
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure
2009
Heterogeneity of kinase inhibitor resistance mechanisms in GIST
2008
Novel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors
2008
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
2010 StandoutScience
Mutations in GNA11 in Uveal Melanoma
2010 Standout
Malignant melanoma: genetics and therapeutics in the genomic era
2006
The cancer genome
2009 StandoutNature
I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development
2010 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas
2005
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
2008
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, against Gastrointestinal Stromal Tumor–Associated PDGFRAD842V Mutation
2008
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)
2017
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Molecular Pathobiology of Gastrointestinal Stromal Sarcomas
2008
Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study
2006
Advances in Targeting Src in the Treatment of Breast Cancer and Other Solid Malignancies
2010
Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma
2016 StandoutNobel
Emerging Insights into the Molecular Pathogenesis of Uveal Melanoma
2008
Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors
2006
KIT Gene Mutations and Copy Number in Melanoma Subtypes
2008
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
PDGF Receptors in Tumor Biology: Prognostic and Predictive Potential
2014
Regulation of interleukin-12 production in antigen-presenting cells
2001
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Works of Arin Schroeder being referenced
CpG DNA Induced IL-12 p40 Gene Activation Is Independent of STAT1 Activation or Production of Interferon Consensus Sequence Binding Protein
2002
KIT Gene Deletions at the Intron 10−Exon 11 Boundary in GI Stromal Tumors
2004
PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib
2005
CpG DNA induced IL-12 p40 gene activation is independent of STAT1 activation or production of interferon consensus sequence binding protein
2002
Dasatinib (BMS-354825), a Dual SRC/ABL Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane, and Activation Loop Mutant KIT Isoforms Associated with Human Malignancies
2006
Absence of BRAF and NRAS mutations in uveal melanoma.
2003